Clinical Genomics Scientist, Oncology

BillionToOne, Inc.; California (MO); Remote; USD 156,000 - 177,000; Full time

Job summary

An innovative firm is seeking a Clinical Genomics Scientist to enhance patient care through precise somatic variant interpretation. This role involves drafting clinical reports and developing interpretation policies in a dynamic team environment. With a focus on oncology, you'll leverage cutting-edge technology to impact patient outcomes significantly. Join a company that values diversity and innovation, offering competitive compensation and exceptional benefits, including generous parental leave and a supportive work culture. This is an exciting opportunity to contribute to groundbreaking advancements in molecular diagnostics.

Benefits

Free healthcare options

401k match

Generous parental leave

Free daily on-site lunches

Latest hardware

State of the art gym

Free on-site EV charging

Qualifications

• 2+ years of experience in somatic variant interpretation in a clinical setting.
• Familiarity with ACMG/AMP guidelines and bioinformatics tools.

Responsibilities

• Perform somatic variant interpretation and data review for clinical reports.
• Draft clinical reports using in-house reporting API and collaborate with teams.

Skills

Somatic variant interpretation

Report drafting

Data analysis

Bioinformatics tools

Attention to detail

Communication skills

Education

Ph.D. in Human Genetics

M.S. in Genetic Counseling

Tools

IGV

BAM file analysis

Job description

BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.

BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024 , highlighting the company's exceptional work environment and commitment to innovation.

Our team has grown significantly and despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com .

BillionToOne is looking for a Clinical Genomics Scientist, Oncology to help drive somatic mutation variant interpretation and reporting. BillionToOne has recently launched two oncology liquid biopsy products : Northstar Select and Northstar Response for late-stage solid-tumor cancer patients. Northstar Select is a comprehensive pan-cancer somatic mutation profiling panel. Northstar Response is a methylation-based, tissue-agnostic treatment response monitoring assay.

As a member of the oncology clinical genomics team, you are responsible for helping with day-to-day commercial reporting operations, including variant interpretation and report drafting. Working closely with the medical team, you will develop interpretation and reporting policies based on the latest publications and guidelines, and help scale-up our ever growing reporting needs. This role will report to the Senior Manager of Clinical Genomics, Oncology in a remote-based position or at our Menlo Park location.

If you have a strong commitment to improving patient care through clear clinical reporting, have experience in somatic variant interpretation and report drafting, enjoy digging into the technical side of the data alongside bioinformatics, and thrive in a fast-paced entrepreneurial environment, this could be a perfect opportunity for you.

Key Responsibilities:

• Somatic variant interpretation and data review: Perform somatic-based variant interpretation, diving into the literature and databases to classify variants and match treatments for reporting, performing verification as required with BAM file analysis.
• Clinical report drafting: Carefully draft reports for each requisition primarily using in-house reporting API, working closely with the engineering and QA teams on reporting, and the laboratory directors on report language.
• Somatic mutation interpretation and reporting policy development: Work closely with lab directors, R&D, medical, and other related functions to develop and modify the somatic interpretation SOPs in accordance with ACMG/AMP guidelines, and the latest published literature.
• Content curation: Contribute to curation of gene-level content such as domain and critical residue curation.Molecular tumor board: Serve as a subject matter expert in consulting with the medical science liaison team, and presenting in molecular tumor boards to facilitate knowledge sharing.
• Contribute to oncology R&D: Work closely with the R&D team to help with somatic oncology based projects, providing expertise on variant interpretation, biological pathways/mechanisms, and other gene/variant-level reviews and analyses.

Requirements

• Ph.D. in Human Genetics, M.S. in Genetic Counseling, or related field
• 2+ years of experience in somatic variant interpretation based on ACMG/AMP guidelines in a clinical setting (alternatively, 1+ years of germline variant interpretation and 1+ years of somatic variant interpretation experience)
• Familiarity with IGV and BAM file analysis and data-minded willingness to learn to use basic bioinformatics tools, with technically minded insights
• Knowledge of cancer somatic mutation and signaling pathways (e.g., which mutations have FDA approved drugs, Phase II/III clinical trials, which mutations are considered “hot targets” for drug development, etc.)
• Exceptional attention to detail to follow highly detailed SOPs and strong organizational skills to track and manage clinical reporting and product improvement projects
• Excellent communication skills and ability to work collaboratively with cross-functional teams
• Operationally-defined flexible schedule, including weekends, as dictated by clinical reporting needs
• Working with a team of ‘rockstars’ who bring out the best in everyone
• Open, transparent culture that includes weekly Town Hall meetings
• The ability to indirectly or directly change the lives of hundreds of thousands patients
• Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
• Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
• Retirement savings program including a 4% Company match
• Free daily on-site lunches provided from top eateries
• Latest and greatest hardware (laptop, lab equipment, facilities)
• A variety of perks on campus (state of the art gym, restaurant)
• Free on-site EV charging (compatible with all EVs, including Tesla)

At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses), (2) generous equity options offering, (3) corporate bonus program, on top of (4) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave, etc.).

For this position, we offer a total compensation package of $239,555 per year, including a base pay range of $156,060 - $176,868 per year.

BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

For more information about how we protect your information, we encourage you to review our Privacy Policy .

Apply for this job

*

indicates a required field

First Name *

Last Name *

Email *

Phone

Resume/CV *

Enter manually

Accepted file types: pdf, doc, docx, txt, rtf

Enter manually

Accepted file types: pdf, doc, docx, txt, rtf

LinkedIn Profile

How many years of experience do you have of variant interpretation in a clinical setting, resulting in the issue of clinical reports for blood or tissue based testing? *

How many of the years above involved somatic variant interpretation? *

Are you able to commit to a flexible schedule based on clinical operations needs, including weekends (limited hours) and Pacific time zone business hours? * Select...

Will you now or in the future require sponsorship for employment visa status (e.g. H-1B visa status)? * Select...

What are your salary expectations for this role? *

Were you referred by someone within the company? If yes, please provide their name.